Relaxation of import clearance procedures allows email NOC issuance and testing waivers to expedite critical pharma imports. Importers may submit pharma import applications and documents by email with authorised contact details; the Assistant Drug Controller will review and issue NOC electronically. Temporary acceptance of signed letterhead for labeling/testing guarantees substitutes for notarised stamp paper. Online signed requests may be made for pending Direct Delivery shipments. Vaccines and certain critical IVDs sampled fully may be released after document and protocol review, bank risk certificate and prior track record subject to central regulator conditions. Testing waivers for medicines used by treating physicians for COVID-19 may be allowed based on previous testing history.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Relaxation of import clearance procedures allows email NOC issuance and testing waivers to expedite critical pharma imports.
Importers may submit pharma import applications and documents by email with authorised contact details; the Assistant Drug Controller will review and issue NOC electronically. Temporary acceptance of signed letterhead for labeling/testing guarantees substitutes for notarised stamp paper. Online signed requests may be made for pending Direct Delivery shipments. Vaccines and certain critical IVDs sampled fully may be released after document and protocol review, bank risk certificate and prior track record subject to central regulator conditions. Testing waivers for medicines used by treating physicians for COVID-19 may be allowed based on previous testing history.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.